| Date | Title | Description | Source |
| 14.03.2024 | Rare Disease Advocates Learn to Accelerate Therapeutic Devel... | RARE Drug Development Symposium
The RARE Drug Development Symposium, hosted by Global Genes and the ... | prweb.com/... |
| 05.03.2024 | BridgeBio Pharma Announces Pricing of Public Offering of Com... | - | globenewsw... |
| 04.03.2024 | BridgeBio Pharma Announces Proposed Public Offering of Commo... | PALO ALTO, Calif., March 04, 2024 (GLOBE NEWSWIRE) -- BridgeBio Pharma, Inc. (Nasdaq: BBIO) (“Bridge... | einpresswi... |
| 07.02.2024 | The GLP-1 panic is alive and well | Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech ne... | statnews.c... |
| 18.01.2024 | BridgeBio Pharma Secures up to $1.25 Billion of Capital from... | - | globenewsw... |
| 03.11.2022 | BridgeBio Pharma, Inc. Reports Third Quarter 2022 Financial ... | /EIN News/ -- - Reported positive preclinical data for its next-generation KRASG12C GTP/GDP dual inh... | einpresswi... |
| 18.11.2021 | BridgeBio Pharma : Secures Up to $750 Million in Non-Dilutiv... | BridgeBio Pharma, Inc. Secures Up to $750 Million in Non-Dilutive Debt Financing
-Innovative financi... | marketscre... |
| 18.11.2021 | BridgeBio Pharma, Inc. Secures Up to $750 Million in Non-Dil... | -Innovative financing facility and existing cash balance gives BridgeBio access to over $1.2 billion... | marketscre... |
| 18.11.2021 | BridgeBio Pharma, Inc. Secures Up to $750 Million in Non-Dil... | -Innovative financing facility and existing cash balance gives BridgeBio access to over $1.2 billion... | globenewsw... |
| 03.11.2021 | BridgeBio Pharma Announces Dosing of First Patient in Phase ... | PALO ALTO, Calif., Nov. 3, 2021 /PRNewswire/ -- BridgeBio Pharma, Inc. (Nasdaq: BBIO), a commercial-... | marketscre... |
| 29.10.2021 | BridgeBio Pharma Announces Collaborations with Columbia Univ... | PALO ALTO, Calif., Oct. 29, 2021 /PRNewswire/ -- BridgeBio Pharma, Inc. (Nasdaq: BBIO), a commercial... | marketscre... |
| 12.10.2021 | BridgeBio Pharma : Announces Progress in its KRAS Portfolio,... | PALO ALTO, Calif., Oct. 12, 2021 /PRNewswire/ - BridgeBio Pharma, Inc. (Nasdaq: BBIO), a commercial-... | marketscre... |
| 07.10.2021 | BridgeBio Pharma : Announces First Publication of Preclinica... | -Preclinical findings that demonstrated efficacy in non-small cell lung cancer (NSCLC) driven by RAS... | marketscre... |
| 15.09.2021 | BridgeBio : Pharma Receives FDA Fast Track Designation for I... | PALO ALTO, Calif., Sept. 15, 2021 /PRNewswire/ -- BridgeBio Pharma, Inc. (Nasdaq: BBIO), a commercia... | marketscre... |
| 15.09.2021 | BridgeBio Pharma Receives FDA Fast Track Designation for Inv... | | prnewswire... |
| 18.08.2021 | BridgeBio Pharma, Inc. Appoints Finance and Pharmaceutical L... | | prnewswire... |
| 18.08.2021 | BridgeBio Pharma : Appoints Finance and Pharmaceutical Leade... | PALO ALTO, CA - August 18, 2021 - BridgeBio Pharma, Inc. (Nasdaq: BBIO), a commercial-stage biopharm... | marketscre... |
| 05.08.2021 | BridgeBio Pharma, Inc. Reports Second Quarter 2021 Financial... | | prnewswire... |
| 27.07.2021 | BridgeBio Announces Clinical Collaboration with Bristol Myer... | | prnewswire... |
| 27.07.2021 | BridgeBio : Announces Clinical Collaboration with Bristol My... | PALO ALTO, Calif., July 27, 2021 /PRNewswire/ -- BridgeBio Pharma, Inc. (Nasdaq: BBIO) (BridgeBio), ... | marketscre... |
| 08.07.2021 | BridgeBio Pharma Announces Collaborations with Three Academi... | | prnewswire... |
| 08.07.2021 | BridgeBio : Pharma Announces Collaborations with Three Acade... | PALO ALTO, Calif., July 8, 2021 /PRNewswire/ -- BridgeBio Pharma, Inc. (Nasdaq: BBIO), a commercial-... | marketscre... |
| 14.08.2020 | Canada’s Atomwise secures 163M CAD in Series B funding | The AI-driven drug discovery platform was founded in 2012 by Abraham Heifets, Alexander Levy and Dr.... | vcbay.news... |
| 11.08.2020 | Perceptive debuts LianBio with cancer and heart disease prog... | After working in stealth since October, Perceptive Advisors is unveiling its latest biotech: LianBio... | fiercebiot... |
| 11.08.2020 | Perceptive debuts LianBio with cancer and heart disease prog... | After working in stealth since October, Perceptive Advisors is unveiling its latest biotech: LianBio... | fiercebiot... |
| 10.06.2020 | BIO: BridgeBio CEO Kumar on its 'hub-and-spoke' model and wh... | Five years ago, Neil Kumar, Ph.D., quit his job at Third Rock Ventures to start a new kind of biotec... | fiercebiot... |
| 10.06.2020 | BIO: BridgeBio CEO Kumar on its 'hub-and-spoke' model and wh... | Five years ago, Neil Kumar, Ph.D., quit his job at Third Rock Ventures to start a new kind of biotec... | fiercebiot... |
| 20.12.2019 | Bill Lundberg takes over the reins at Merus; Former Akcea ... | Bill Lundberg
→ Dutch biotech Merus, who struck up a $200 million bispecific development dea... | endpts.com... |
| 15.10.2019 | BridgeBio terminates effort to acquire remainder of Eidos Th... | Eidos trades publicly on the Nasdaq, and its shares fell 6.5 percent Monday morning following the ne... | medcitynew... |
| 28.05.2019 | BridgeBio files for $225M initial public offering | The company was formed in 2015 and adopted a model developed at the Massachusetts Institute of Techn... | medcitynew... |
| 26.01.2019 | BridgeBio Pharma Closes $299.2 Million Financing Round to Su... | PALO ALTO, Calif.–(BUSINESS WIRE)–BridgeBio Pharma, a clinical-stage biopharmaceutical company focus... | aislingcap... |
| 25.01.2019 | Term Sheet — Friday, January 25 | CHINA’S PRIVATE EQUITY KING
Happy Friday, Term Sheet readers.
Paid Content Keeping business secure i... | fortune.co... |
| 25.01.2019 | Daily funding roundup - January 25th, 2019 | AirWorks Solutions raised $2.3M; RealBlocks raised $3.1M; 7shifts raised $10M
AirWorks Solutions: Ai... | vator.tv/n... |
| 24.01.2019 | BridgeBio Pharma Receives $299.2M |
PALO ALTO, CA, BridgeBio Pharma, a clinical-stage biopharmaceutical company focused on genetic dis... | vcnewsdail... |
| 23.01.2019 | BridgeBio Pharma Closes $299.2 Million Financing Round to Su... | PALO ALTO, Calif.--(BUSINESS WIRE)--BridgeBio Pharma, a clinical-stage biopharmaceutical company foc... | media.kkr.... |
| 23.01.2019 | BridgeBio Pharma raises $299.2M in financing round | The company plans to use the money support and expand upon existing research and development program... | medcitynew... |
| 23.01.2019 | BridgeBio Pharma Closes $299.2M Financing Round | BridgeBio Pharma, a Palo Alto, CA-based clinical-stage biopharmaceutical company focused on genetic ... | finsmes.co... |
| 14.09.2017 | Term Sheet — Thursday, September 14 | UNICORN STATUS
Good morning, Term Sheet readers.
Paid Content You can't secure what you can't see Fr... | fortune.co... |
| 13.09.2017 | BridgeBio Pharma expands investor base, raising an additiona... | PALO ALTO, Calif., Sept. 13, 2017 /PRNewswire/ — BridgeBio Pharma, a clinical-stage biopharmaceutica... | aislingcap... |
| 13.09.2017 | BridgeBio Pharma Raises Additional $135M in Funding | BridgeBio Pharma, a Palo Alto, CA-based clinical-stage biopharmaceutical company, raised an addition... | finsmes.co... |
| 13.09.2017 | A biotech company focused on inherited diseases just raised ... | Courtsey BridgeBio
BridgeBio CEO Neil Kumar
A biotech focused on developing drugs to treat genetic d... | businessin... |
| - | BridgeBio Pharma raises $299.2M in financing round | A company focused on developing genetically targeted drugs discovered by academia and then building ... | medcitynew... |
| - | BridgeBio terminates effort to acquire remainder of Eidos Th... | A firm that helps launch biomedical research into new companies has called off a bid to acquire one ... | medcitynew... |
| - | BridgeBio files for $225M initial public offering | A company that turns research in genetically driven diseases into subsidiary companies has filed to ... | medcitynew... |